Novel UH therapies for treating heart failure being developed
Makai Biotechnology is licensing technology developed by UH’s Alexander Stokes to develop new cardiovascular drugs aimed at treating and preventing heart failure.
Makai Biotechnology is licensing technology developed by UH’s Alexander Stokes to develop new cardiovascular drugs aimed at treating and preventing heart failure.
J. Kūhiō Asam, Claire L. Asam, Rick Blangiardi, Emme Tomimbang and John Waiheʻe honored as 2014 UH Distinguished Alumni.
John A. Burns School of Medicine researcher Ben Fogelgren is recipient of $150,000 funding grant.
The University of Âé¶¹´«Ã½ spring commencement schedule.
John A. Burns School of Medicine second-year medical student Brandyn Dunn was awarded the 2014 Excellence in Public Health Award.
Medical students at the John A. Burns School of Medicine learn where they will spend their professional residencies.
The John A. Burns School of Medicine moved up in the 2014 U.S. News and World Report lists of Best U.S. Medical Schools in both primary care and research.
Gov. Abercrombie appoints JABSOM faculty member Linda Rosen as director of the Department of Health.
JABSOM uses mobile health van funded by Walmart to provide free outreach services for homeless.
UH Mānoa and New Zealand universities establish international indigenous research partnership.